# REYATAZ

NDC: 0003-3631
Generic name: ATAZANAVIR
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20030624

FDA application: NDA021567

## Active ingredients

- ATAZANAVIR SULFATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-3631"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-3631
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8